BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25040564)

  • 1. Intestinal metaplasia in Barrett's oesophagus may be an epiphenomenon rather than a preneoplastic condition, and CDX2-positive cardiac-type epithelium is associated with minute Barrett's tumour.
    Watanabe G; Ajioka Y; Takeuchi M; Annenkov A; Kato T; Watanabe K; Tani Y; Ikegami K; Yokota Y; Fukuda M
    Histopathology; 2015 Jan; 66(2):201-14. PubMed ID: 25040564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells?
    Kerkhof M; Bax DA; Moons LM; van Vuuren AJ; van Dekken H; Steyerberg EW; Kuipers EJ; Kusters JG; Siersema PD;
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1613-21. PubMed ID: 17206949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
    Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S
    World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
    Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
    Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
    Phillips RW; Frierson HF; Moskaluk CA
    Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma--a possible biomarker to predict the malignant potential of Barrett's oesophagus.
    Iwaya Y; Hasebe O; Koide N; Kitahara K; Suga T; Shinji A; Muraki T; Yokosawa S; Yamada S; Arakura N; Tanaka E; Nakayama J
    Histopathology; 2014 Mar; 64(4):536-46. PubMed ID: 24117499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry for CDX2 expression in non-goblet-cell Barrett's oesophagus.
    Behan M; Gledhill A; Hayes S
    Br J Biomed Sci; 2014; 71(2):86-92. PubMed ID: 24974686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDX2 and LI-cadherin expression in esophageal mucosa: use of both markers can facilitate the histologic diagnosis of Barrett's esophagus and carcinoma.
    Weimann A; Zimmermann M; Gross M; Slevogt H; Rieger A; Morawietz L
    Int J Surg Pathol; 2010 Oct; 18(5):330-7. PubMed ID: 20444732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of Barrett's oesophagus.
    Van Eyken P
    Acta Gastroenterol Belg; 2000; 63(1):10-2. PubMed ID: 10907312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium.
    Kazumori H; Ishihara S; Rumi MA; Kadowaki Y; Kinoshita Y
    Gut; 2006 Jan; 55(1):16-25. PubMed ID: 16118348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.
    Vallböhmer D; DeMeester SR; Peters JH; Oh DS; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; DeMeester TR; Chandrasoma PT
    Dis Esophagus; 2006; 19(4):260-6. PubMed ID: 16866857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
    Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
    Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development.
    Kazumori H; Ishihara S; Kinoshita Y
    Gut; 2009 May; 58(5):620-8. PubMed ID: 19136512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
    Schilling D; Spiethoff A; Rosenbaum A; Hartmann D; Eickhoff A; Jakobs R; Weickert U; Rebe M; Bohrer MH; Riemann JF
    Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.
    Groisman GM; Amar M; Meir A
    Mod Pathol; 2004 Oct; 17(10):1282-8. PubMed ID: 15167938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.
    Villanacci V; Rossi E; Zambelli C; Galletti A; Cestari R; Missale G; Casa DD; Bassotti G
    Dig Liver Dis; 2007 Apr; 39(4):305-11. PubMed ID: 17307036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.
    Pascarenco OD; Boeriu A; Mocan S; Pascarenco G; Drasoveanu S; Galeanu M; Dobru D
    J Gastrointestin Liver Dis; 2014 Mar; 23(1):19-25. PubMed ID: 24689092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
    Chinyama CN; Marshall RE; Owen WJ; Mason RC; Kothari D; Wilkinson ML; Sanderson JD
    Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.